SCHEMBL1660381

SCHEMBL1660381

CC(C)c1ccc(I)c(Oc2nc(C(=O)O)co2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.34
EIF4A3 P38919 1/20 0.34
BCHE P06276 3/20 0.34
ACHE P22303 3/20 0.34
IKBKE Q14164 2/20 0.33
TBK1 Q9UHD2 2/20 0.33
GPR35 Q9HC97 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ABCC4 O15439 1/20 0.33
TTR P02766 1/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRD1 P41143 1/20 0.33
RAB9A P51151 1/20 0.33
PDE4D Q08499 1/20 0.33
PDE3A Q14432 1/20 0.33
KLKB1 P03952 1/20 0.32
P2RX3 P56373 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660892 0.86 BCHE (0.42) NLRP3BCHEACHE
SCHEMBL2871922 0.79 P2RX3 (0.45) KDM4ENPC1RAB9AKLKB1P2RX3
SCHEMBL12563381 0.79 PDE2A (0.41) NLRP3
SCHEMBL12697437 0.78 PDE2A (0.38)
SCHEMBL1660196 0.78 PTGS1 (0.45) KDM4EKLKB1P2RX3PLGPLAU
SCHEMBL1660174 0.75 PDE2A (0.36) NLRP3
SCHEMBL12604119 0.75 PDE2A (0.36) NLRP3
SCHEMBL2638909 0.74 P2RX3 (0.40) KLKB1P2RX3
SCHEMBL2875569 0.69 CTSA (0.42) KDM4EMAPT
SCHEMBL1660857 0.69 PPARG (0.33) KLKB1P2RX3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP disclosed
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed